Month: September 2015

Terumo Invests in Quirem Medical, Focusing on Interventional Oncology Field

September 9th, 2015 – Terumo Corporation (Headquarters: Shibuya-ku, Tokyo, Japan; President: Yutaro Shintaku) and Quirem Medical B.V., a commercial stage Dutch medical technology company that focuses on radioembolization, today announced that Terumo has made an equity investment in Quirem Medical. Quirem Medical develops QuiremSpheres™, next generation microspheres for the radioembolization treatment

Read More »